Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Level 39, Canary Wharf.

  1. Events
  2. Venues
  3. Level 39, Canary Wharf.
Events at this venue
Today

London Healthcare Innovation Forum

Bringing together leaders from healthcare, technology, investment, and policy, the London Healthcare Innovation Forum is designed to tackle the biggest challenges in healthcare innovation. This [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2024 | Hlx Life Sciences

Site by theLEAP

Go to Top